These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 11903824)

  • 1. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
    Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
    J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
    Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
    Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of HIV associated oral lesions among adults in the era of HAART.
    Mthethwa SR; Wanjau J; Chabikuli N
    SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.
    Ramírez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Anaya-Saavedra G; González-Ramírez I; Ponce-de-León S
    Medicine (Baltimore); 2003 Jan; 82(1):39-50. PubMed ID: 12544709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
    Tappuni AR; Fleming GJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
    Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
    Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review.
    Ottria L; Lauritano D; Oberti L; Candotto V; Cura F; Tagliabue A; Tettamanti L
    J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):51-59. PubMed ID: 29460518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
    Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
    AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
    Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
    Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of oral mucosal lesions in human immunodeficiency virus-infected children attending the Pediatric Infectious Diseases Clinic in Cape Town.
    Mulder R; Mohamed N; Mathiba O
    Clin Exp Dent Res; 2022 Feb; 8(1):160-168. PubMed ID: 34586712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population.
    Margiotta V; Campisi G; Mancuso S; Accurso V; Abbadessa V
    J Oral Pathol Med; 1999 Apr; 28(4):173-7. PubMed ID: 10235371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a Southeastern US clinic.
    Tamí-Maury I; Willig J; Vermund S; Jolly P; Aban I; Hill J; Wilson CM
    J Public Health Dent; 2011; 71(4):257-64. PubMed ID: 22320283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral lesions in Brazilian HIV-infected children undergoing HAART.
    Miziara ID; Filho BC; Weber R
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.
    Cu-Uvin S; Caliendo AM; Reinert S; Chang A; Juliano-Remollino C; Flanigan TP; Mayer KH; Carpenter CC
    AIDS; 2000 Mar; 14(4):415-21. PubMed ID: 10770544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: oral lesions in HIV/AIDS patients undergoing HAART including efavirenz.
    Aquino-García SI; Rivas MA; Ceballos-Salobreña A; Acosta-Gio AE; Gaitán-Cepeda LA
    AIDS Res Hum Retroviruses; 2008 Jun; 24(6):815-20. PubMed ID: 18507528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.
    Schmidt-Westhausen AM; Priepke F; Bergmann FJ; Reichart PA
    J Oral Pathol Med; 2000 Aug; 29(7):336-41. PubMed ID: 10947250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.
    Duggal MS; Abudiak H; Dunn C; Tong HJ; Munyombwe T
    Eur Arch Paediatr Dent; 2010 Oct; 11(5):242-6. PubMed ID: 20932399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).
    Greenspan D; Komaroff E; Redford M; Phelan JA; Navazesh M; Alves ME; Kamrath H; Mulligan R; Barr CE; Greenspan JS
    J Acquir Immune Defic Syndr; 2000 Sep; 25(1):44-50. PubMed ID: 11064503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.